Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
CFO · Nexalin Technology, Inc. · Nexalin Technology, Inc. — Stock Option (right to buy)*
Grant or award — administrative, little informational value
No reported dollar value · 76.7% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Kazden AlanDirector | Grant or award | A | — 100.0K sh | Dec 23, 2025 traded Dec 19, 2025 | |
| 21 | Owens DavidDirector, Chief Medical Officer | Grant or award | A | — 1.00M sh | Dec 23, 2025 traded Dec 19, 2025 | |
| 9 | Hu BenDirector | Grant or award | A | — 100.0K sh | Dec 23, 2025 traded Dec 19, 2025 | |
| 21 | Shelton Carolyn HambySr. VP - Quality - Regulatory | Grant or award | A | — 100.0K sh | Dec 23, 2025 traded Dec 19, 2025 | |
| 21 | White MarkDirector, CEO | Grant or award | A | — 1.00M sh | Dec 23, 2025 traded Dec 19, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Van Fleet Justin filed this Form 4 reporting a grant or award of NXL on Dec 19, 2025. It became public on Dec 23, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.